October 17, 2025

Universität Heidelberg: Successful Placement in Times Higher Education Rankings

Universität Heidelberg: Successful Placement in Times Higher Education Rankings

Ruperto Carola is ranked among the world’s “Top 50” and one of the top three universities in Germany

Heidelberg University is one of the top three universities in Germany, ranking third in the 2025/2026 Times Higher Education World University Rankings, which have just been published. In 49th position internationally, it is among the world’s “Top 50” as in the previous year – one of only three German universities to earn that distinction. In the Europe-wide comparison, Ruperto Carola is placing 13th in the THE Rankings.

In Germany, Heidelberg University is among the “Top 50” universities in the world, along with the two universities in Munich. Taking first place at the national level, Technical University of Munich ranks 27th internationally. LMU Munich, second in Germany, is in 34th position in the global comparison. Five other German universities are among the “Top 100” universities, ranked 89th, 91st, 92nd (shared) and 98th.

The Times Higher Education (THE) World University Rankings, published on 9 October 2025, are based on a total of 18 different indicators. They are grouped into five areas of performance. These are, above all, teaching (learning environment), research environment and research quality. Other areas analyzed include aspects of internationalization and industry. This year’s THE Rankings feature 2,191 institutions from 115 countries/regions.

Further information

Our latest News

discover more
Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Effective June 1, 2026, the Supervisory Board has appointed Hanns-Peter Knaebel, Chairman of the Executive Board, to serve as Chief Medical Officer. This move will ensure that the dynamic phase of medical strategy development and transformation within the group is overseen and managed centrally by the full Executive Board. Full Text in German below. Professor […]

ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

HEILBRONN, Germany, May 14, 2026 – ProtaGene today announced a strategic partnership with the Life Science business of Merck, which operates as MilliporeSigma in the United States and Canada, to provide biopharmaceutical customers with an end-to-end testing solution across the entire biopharmaceutical product lifecycle, from early-stage development through GMP release testing. ProtaGene’s expertise in advanced protein […]

Universität Heidelberg Successful with Application for Collaborative Research Centre

Universität Heidelberg Successful with Application for Collaborative Research Centre

DFG funds extended CRC with approximately 17.4 million euros Heidelberg University has been successful in the latest approval round of the German Research Foundation (DFG) with a grant application for a major research consortium: The Collaborative Research Centre “Molecular Circuits of Heart Disease” (CRC 1550), based at the Medical Faculty Heidelberg, is entering a second […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp